Peer-reviewedCC BY-NC-NDTranslational cancer research
A narrative review of barrier-matched engineering of macrophages for solid tumor immunotherapy: design logic, translational barriers and clinical outlook
- 1Huzhou Central Hospital , Fifth School of Clinical Medicine of Zhejiang Chinese Medical University , Huzhou , ;
- 2Huzhou Central Hospital , Huzhou , ;
- 3Huzhou Central Hospital , Affiliated Central Hospital of Huzhou Normal University , Huzhou ,
Related
- Cellular immunotherapy for lung cancer: current clinical evidence, translational challenges, and future perspectives: a narrative review
- Disruption of the ARID1A-containing SWI/SNF complex reprograms tumor-associated macrophages and enhances immunotherapy response
- Tumor-associated macrophages beyond M1/M2 in NSCLC: spatially organized programs, therapy resistance, and translational targeting
- Strategic engineering B cell immunity for cancer immunotherapy
- Engineering an arginine-nitric oxide circuit in Escherichia coli Nissle 1917 to remodel the tumor microenvironment for enhanced immunotherapy: a review
BibTeX
@article{wu2026narrative,
title = {{A narrative review of barrier-matched engineering of macrophages for solid tumor immunotherapy: design logic, translational barriers and clinical outlook}},
author = {Jian Wu and Jiabao Dong and Yi Shen and Haoyun Yu and Miyang Xu and Jiangfeng Zhang and Wei Wei and Xiongfeng Li},
journal = {Translational cancer research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657824},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - A narrative review of barrier-matched engineering of macrophages for solid tumor immunotherapy: design logic, translational barriers and clinical outlook
AU - Jian Wu
AU - Jiabao Dong
AU - Yi Shen
AU - Haoyun Yu
AU - Miyang Xu
AU - Jiangfeng Zhang
AU - Wei Wei
AU - Xiongfeng Li
PY - 2026
DA - 2026/08/31
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657824
SN - 2218-676X
ER -